Document is current
Any future updates will be listed below
-
Authors
Hitora, Yusuke
Teraoka, Tsubasa
Tanaka, Akihito https://orcid.org/0000-0003-2260-1942
Uemura, Yusuke
Tobe, Akihiro
Sakakibara, Keisuke
Miki, Yusuke
Kataoka, Takashi
Niwa, Kiyoshi
Tashiro, Hiroshi
Furusawa, Kenji
Takemoto, Kenji
Watarai, Masato
Kimura, Akira
Ishii, Hideki
Murohara, Toyoaki
- License Information
-
More Information
Article History
Received: 22 July 2020
Accepted: 22 October 2020
First Online: 9 November 2020
Compliance with ethical standards
:
: Hideki Ishii received lecture fees from Astellas Pharma Inc., Astrazeneca Inc., Daiichi-Sankyo Pharma Inc., and MSD K. K. Yusuke Uemura received lecture fees from Otsuka Pharma Ltd. Toyoaki Murohara received lecture fees from Bayel Pharmaceutical Co., Ltd., Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., MSD K. K., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K. K., Pfizer Japan Inc., Sanofi-aventis K. K., and Takeda Pharmaceutical Co., Ltd. Toyoaki Murohara received unrestricted research grant for Department of Cardiology, Nagoya University Graduate School of Medicine from Astellas Pharma Inc., Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., MSD K. K., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K. K., Otsuka Pharma Ltd., Pfizer Japan Inc., Sanofi-aventis K. K., Takeda Pharmaceutical Co., Ltd., and Teijin Pharma Ltd. All the other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
